Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia

J Fang, LC Bolanos, K Choi, X Liu, S Christie… - Nature …, 2017 - nature.com
J Fang, LC Bolanos, K Choi, X Liu, S Christie, S Akunuru, R Kumar, D Wang, X Chen
Nature immunology, 2017nature.com
Toll-like receptor (TLR) activation contributes to premalignant hematologic conditions, such
as myelodysplastic syndromes (MDS). TRAF6, a TLR effector with ubiquitin (Ub) ligase
activity, is overexpressed in MDS hematopoietic stem/progenitor cells (HSPCs). We found
that TRAF6 overexpression in mouse HSPC results in impaired hematopoiesis and bone
marrow failure. Using a global Ub screen, we identified hnRNPA1, an RNA-binding protein
and auxiliary splicing factor, as a substrate of TRAF6. TRAF6 ubiquitination of hnRNPA1 …
Abstract
Toll-like receptor (TLR) activation contributes to premalignant hematologic conditions, such as myelodysplastic syndromes (MDS). TRAF6, a TLR effector with ubiquitin (Ub) ligase activity, is overexpressed in MDS hematopoietic stem/progenitor cells (HSPCs). We found that TRAF6 overexpression in mouse HSPC results in impaired hematopoiesis and bone marrow failure. Using a global Ub screen, we identified hnRNPA1, an RNA-binding protein and auxiliary splicing factor, as a substrate of TRAF6. TRAF6 ubiquitination of hnRNPA1 regulated alternative splicing of Arhgap1, which resulted in activation of the GTP-binding Rho family protein Cdc42 and accounted for hematopoietic defects in TRAF6-expressing HSPCs. These results implicate Ub signaling in coordinating RNA processing by TLR pathways during an immune response and in premalignant hematologic diseases, such as MDS.
nature.com